Peer Review History
| Original SubmissionDecember 22, 2022 |
|---|
|
PONE-D-22-35091Functional characterization of p62/SQSTM1 in the vector Rhodnius prolixus reveals a high degree of sequence conservation but no apparent deficiency-related phenotypes in vitellogenic femalesPLOS ONE Dear Dr. Ramos, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 19 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Joshua B. Benoit Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed: https://onlinelibrary.wiley.com/doi/10.1002/jcp.30806 In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Please expand the acronym “JCNE-FAPERJ, INCT-EM-CNPq/FAPERJ, CAPES” (as indicated in your financial disclosure) so that it states the name of your funders in full. This information should be included in your cover letter; we will change the online submission form on your behalf. 5. Thank you for stating the following in the Acknowledgments Section of your manuscript: "The authors thank CENABIO-UFRJ and the funding agencies FAPERJ, CNPq and CAPES" We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "This research was funded by the following grants: JCNE-FAPERJ (www.faperj.br/), INCT-EM-CNPq/FAPERJ (http://cnpq.br/) and CAPES (www.capes.gov.br/) to I.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 6. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. 7. Please upload a new copy of Figure 1 and 8 as the detail is not clear. Please follow the link for more information: https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/ https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/ 8. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Additional Editor Comments: The reviewers have indicated that there are considerable issues that must be addressed before reconsideration. This will likely require a combination of extensive editing and some additional analyses. Importantly, the reviewers had a split decision on acceptance (one suggested revision and the other suggested reject), so the manuscript will be sent for review again after revision. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: General comments: The manuscript by Pereira et al. studies the autophagy/UPS adaptor protein p62 in the hematophagous model insect Rhodnius prolixus, a vector of Chagas disease. To do so, the authors employed biochemical and molecular biological approaches, including gene silencing. The article addresses an interesting topic, as little information is available on p62 in insects, apart from what has been reported in Drosophila. The manuscript is well organized and written. The objectives and experimental design are clear and straightforward. Broadly, the article is divided into two parts, the first descriptive and the second functional. Although the gene description (sequence, domain, phylogenetic analysis) is well done, I am concerned that the manuscript fails to attribute a functional role to p62 as the evidence obtained is negative. The authors should have performed additional experiments explaining why silencing the p62 gene did not produce any observable phenotype. Specific comments: Pages 11-12, section "Parental RNAi silencing of p62...": The authors mention three possible explanations for why the silenced insects showed no change in phenotype, but did not pursue those options. A quick Internet search shows several major antibody suppliers providing anti-p62 polyclonal options that could cross-react against the Rhodnius protein. There is even an antibody that is described as reacting against "invertebrate" p62 and is therefore worth testing (https://www.novusbio.com/products/p62-sqstm1-antibody_nbp1-48320). Since the title of the article reports that this is a "functional characterization" of the p62, more experiments that attempt to shed light on the function of the protein should be included. - Page 8, first paragraph: citations are missing. Please include them. - Page 10, first line: "melpomene" should not be in capital letters. Please correct. - Page 10, second line: "lectularius" is misspelled. Please correct. - Page 10, third line: "Daphnia" is misspelled. Please correct. - Table S1: The word "list" should not be capitalized. Please correct. - Page 10, RNAi silencing section: There is a space missing between "606" and "bp". Please add. Please revise this aspect (space between magnitudes and their respective units) throughout the manuscript. - Page 11, "Yolk organelles..." section: No need to capitalize "flow cytometry" in the title. - Fig. 1 has low resolution. Please upload an improved image. - Page 11, "The single isoform..." section, last paragraph: "R. prolixus" needs to be italicized. Please correct. Reviewer #2: The authors propose the genomic and transcriptional characterization of the protein p62 and the study of its relevance during the vitellogenesis of the Chagas ‘disease vector Rhodnius prolixus. In my opinion, the manuscript only resolves the aspect related with the genomic characterization of the protein. Moreover, the phylogenetic analysis is not representative. The authors claim that the identity of the protein is confirmed based on its occurrence in same clade with Drosophila melanogaster but, at the same time is true that Daphnia pulex (Crustacea) appears in the clade more proximal to the hemipteran species than D. melanogaster and Anopheles gambiae. Furthermore, it is not clear the reasons why the authors include in the phylogenetic analysis other related proteins. It seems to be not necessary. Otherwise, each one of these analysis involving other proteins, if are trully relevant, should be performed independently of the P62 analysis. Finally, the trees in the current form should not be included. Furthermore, the authors claim that the gene is absent in Aedes aegypti and other species pertaining to other insect orders. It seems not probable the the protein could be lost in Ae. aegypti, being present in the related genus Anopheles. Indeed, it seems not probable that this protein could be lost along insect evolution. It would more probable that the authors didn´t find the corresponding sequences in the genomes. Regarding the experimental designs, a number of situations are not clear. Why the authors used females after two or three feeding cycles. Why didn´t use females on the first cycle? I assume that on the first cycle they can get a more accurate standardization of the individuals used for experiments. It is also not clear, when the silencing treatments were done. RNAi silencing treatment of unfed females means first blood feeding as adults as it can be interpreted from M&M section? It means that experimental data were taken after more than 30 days after treatment? Any way, if the females were fed three times, is possible to analyse them in a synchronized physiological condition? The authors also claim that p62 might be not relevant under in-house conditions! Is this possible? Are the physiology of the insects different in house-conditions? Minor comments: - “Heliconius Melpomene” must be “Heliconius melpomene” - “Cimex letularius” is “Cimex lectularius” - “Daphia pulex” should be changed by “Daphnia pulex” Finally, we found that the manuscript present both experimental and theoretical failures to be published in the current form. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-35091R1Gene identification and RNAi-silencing of p62/SQSTM1 in the vector Rhodnius prolixus reveals a high degree of sequence conservation but no apparent deficiency-related phenotypes in vitellogenic femalesPLOS ONE Dear Dr. Ramos, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 02 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Joshua B. Benoit Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): The reviewers have suggested a few additional minor comments. After these are addressed, I'll accept the paper. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In the revised version of the MS, the authors have added experiments to improve the articulation between the objective and the hypothesis. They have changed the title to fit the physiological context of the results. In addition, the authors have improved the resolution of the figures. The experimental designs are adequate. Other aspects related to methodology and results have also been satisfactorily addressed. The sample size is adequate to address the hypothesis. Statistical analyses have been correctly applied. The authors have provided reasonable explanations in the discussion to reinforce the conclusions based on the results obtained. In accordance with suggestions, the discussion section has been greatly improved. Overall, the revised version of the MS has been substantially improved. Reviewer #3: Pereira and colleagues' work describes the function of the gene that encodes for p62, a receptor involved in selective autophagy of ubiquitinated proteins. Although it is one of the most studied factors involved in autophagy, information on insects is scarce, making the authors' work even more interesting, especially since they use R. prolixus as a model. This triatomine species is one of the most important vectors of Chagas disease, a neglected pathology according to WHO that affects millions of people around the world. The authors first conduct a descriptive analysis of the p62 gene using bioinformatic and molecular analyses, and then a functional analysis using mostly molecular analyses. The manuscript is very well written, with some minor errors that I detail below. My main concern, in line with reviewer 1, is the lack of protein-level analysis of p62. While it would be very interesting to evaluate this protein in this model, the work could be published with a more molecular focus. I detail some suggestions below. I agree with reviewer one that the authors should better explain why silencing the p62 gene does not produce an observable phenotype. One of these options, as I mentioned before, is to evaluate protein levels either in tissues or at the peripheral level. The authors mention three possible explanations for why phenotypes are not observed: 1) the protein is not essential for the analyzed phenotypes, 2) although silencing was effective, protein levels are not reduced due to various factors, and 3) silencing p62 activates compensatory mechanisms. Regarding the explanation provided by the authors for hypothesis #1, that potential changes in phenotypes cannot be ruled out if the gene decreases its expression for some reason, this is only true if double-stranded RNA specific to p62 is specifically silenced in nature, which is unlikely. Regarding the authors' explanation of hypothesis number 2, the authors responded to reviewer 1 that they tested mRNA levels and found that they decreased, but not protein levels. This is inconsistent with the explanation they provide below, as they were not able to measure protein levels, so it is unclear whether the lack of phenotype may be caused by a compensatory mechanism. To test the protein, the authors used a non-commercial antibody, as in their experience, commercial antibodies were not effective. However, their antibody also did not appear to be effective, as the bands observed in Figure S4 did not correspond to the expected molecular weight. Therefore, I suggest not adding this information. To investigate phenotypic changes caused by the lack of a protein, it is necessary to determine whether the levels of that protein have actually been decreased. It is also possible that the correct phenotype or "read out" is not being evaluated. To explain this hypothesis, the authors evaluate through qPCR that gene silencing is maintained over time, which would explain that the lack of observable phenotype is not due to transient silencing. However, it does not fully explain the lack of observable phenotype. They also suggest that this may be due to an unusual stability of the p62 protein. I suggest not using the word "unusual", as protein half-lives can vary widely and conclusions about it cannot be drawn if the protein was not evaluated. I suggest giving the work a more descriptive focus only on the involved gene or evaluating other aspects such as autophagosome formation, as I suggest below. With so little information on p62 in triatomines, I find the information presented in this work by the authors to be very relevant and it would be the starting point for evaluating this protein in more functional analyses in future research. Overall, I think mentioning these hypotheses leaves the reader with the idea that more could have been done, so I suggest not mentioning them if they cannot be explored, as they are very generic and explain what would happen for any gene that is silenced and does not produce observable phenotypes. I believe that the information provided by the authors is sufficient to be published as a descriptive analysis of the p62 gene, without pursuing other objectives that cannot be developed. Regarding the authors' response to reviewer 1, "We have added new experiments and discussion regarding the absence of apparent phenotypes." The added experiments such as SDS-PAGE and immunoblotting do not fully explain the absence of apparent phenotypes. SDS-PAGE does not clarify whether residual protein levels are sufficient to prevent functional changes. Additionally, the observed bands in immunoblotting do not correspond to the expected weight, thus, no conclusions can be drawn from this experiment. The authors may consider evaluating p62 protein levels using ELISA or at least semi-quantitatively using a functional antibody against p62. As previously suggested, if a functional antibody is not available, the authors may need to change the focus of the manuscript and not pursue the proposed hypotheses. Reviewer 1 also suggested that the authors use a commercial antibody; otherwise, we cannot determine which proposed hypothesis is the most suitable. Regarding the phrase "Because the UPS and autophagy are essential intracellular degradation routes and p62 is a key mediator that allows direct crosstalk between these pathways, in this work we investigate the silencing effects of p62 in the context of R. prolixus oogenesis." There are kits available for monitoring autophagy, in which p62 is fused to some fluorescent protein. Perhaps the use of these kits could provide more answers about the function of p62 in the relationship between UPS and autophagy. Maybe the authors have already attempted or are attempting to use some of these methods. A quick internet search yielded some results, such as this: https://www.thermofisher.com/order/catalog/product/P36240). Surely the authors can better address this concern than I can. Later on, the authors present the first functional results. As a suggestion, they could add a three-dimensional modeling to showcase p62, using software for this purpose, such as the I-TASSER package (Yang, J. & Zhang, Y. Protein structure and function prediction using I-TASSER. Curr. Protoc. Bioinform. 52, 5–8 (2015)). It seems to me that this would help the reader to have an idea about the three-dimensional structure of the protein and improve the work aesthetically, but it is not essential for understanding the idea proposed by the authors. Material and methods Insects: For the inexperienced reader, could you clarify how they control whether the females have copulated? References: Are the authors missing in reference 30? Extraction of RNA and cDNA synthesis: Please clarify which method was used for the elimination of genomic DNA and evaluation of RNA integrity. Typically, DNase and 2% agarose gel are used for RNA integrity. PCR / RT-qPCR: Did the authors try to check the PCR and qPCR products on an agarose gel? Are there many non-specific bands in the PCR product compared to the qPCR product? I have this question because they use a much higher annealing temperature, 60°C, in qPCR. In this same section, they use the 18S gene as a reference gene. Please use the citation of Majerowicz et al. 2011 and in the use of the 2ΔΔCt method, Livak and Schmittgen, 2011. RNAi silencing: I recommend that the authors mention the review by Paim et al. 2013. (DOI 10.1111/j.1744-7917.2012.01540.x), which discusses many aspects related to gene silencing in triatomines. Results and discussion Section: The single isoform of R. prolixus p62 is conserved within insects and is expressed in the ovaries, developing oocytes, midgut and fat body of adult vitellogenic females. In the 2nd paragraph plese correct: “Reverse transcription quantitative PCR (RT-qPCR) showed that expression levels of the R. prolixus p62 in vitellogenic females are similar in the fat body, midgut and ovary dissected from vitellogenic females.” By “RT-qPCR showed that expression levels of the R. prolixus p62 are similar in the fat body, midgut and ovary dissected from vitellogenic females”. Section: Parental RNAi silencing of p62 is efficient but leads to no apparent changes in digestion, lifespan, oviposition and embryo viability. It is not very clear what the dotted line corresponding to 100% means. For a better understanding of the reader, I think it would be better to clarify what 100% means and show the expression levels of control individuals, i.e. without the silenced gene. The authors surely have this data. In Figure 3A, the relevance of the experiment is not very clear. I suggest moving it to supplementary data. Fig 6: If the aim is to show the effect of p62 silencing on E1 and vice versa, please show the levels of p62 and E1 in control animals, i.e., those treated with non-related dsRNA. Again, it would be clearer for the reader if the dashed line representing 100% is clarified and the best way to do so is by showing the expression levels of the control. What is the difference between Figure 6B and the authors' previous publication? (Pereira J, Dias R, Ramos I. Knockdown of E1- and E2-ubiquitin enzymes triggers defective chorion biogenesis and modulation of autophagy-related genes in the follicle cells of the vector Rhodnius prolixus. J Cell Physiol. 2022;1:12.). Fig 7. I suggest clarifying in the figure, not only in the text, that the results of the E1 silence were previously published by the authors or only citing them and not showing them in the figure, especially if this treatment does not produce changes in control individuals. Fig 8. The same suggestion as for Figure 7 applies. The experiments related to E1 were previously published by the authors in Pereira J, Dias R, Ramos I. Knockdown of E1- and E2-ubiquitin enzymes triggers defective chorion biogenesis and modulation of autophagy-related genes in the follicle cells of the vector Rhodnius prolixus. J Cell Physiol. 2022;1:12. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: Yes: Fabian Orlando Ramos PhD. Facultad de Ciencias Químicas Universidad Nacional de Córdoba ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Gene identification and RNAi-silencing of p62/SQSTM1 in the vector Rhodnius prolixus reveals a high degree of sequence conservation but no apparent deficiency-related phenotypes in vitellogenic females PONE-D-22-35091R2 Dear Dr. Ramos, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Joshua B. Benoit Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-35091R2 Gene identification and RNAi-silencing of p62/SQSTM1 in the vector Rhodnius prolixus reveals a high degree of sequence conservation but no apparent deficiency-related phenotypes in vitellogenic females Dear Dr. Ramos: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Joshua B. Benoit Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .